Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37251 - 37275 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	GAB1	2549	downregulated	entinostat results in decreased expression of GAB1 mRNA	4q31.21	A21037
Entinostat	Investigational	GABBR2	9568	upregulated	entinostat results in increased expression of GABBR2 mRNA	9q22.33	A21037
Entinostat	Investigational	GABRA5	2558	upregulated	entinostat results in increased expression of GABRA5 mRNA	15q12	A21037
Entinostat	Investigational	GABRB1	2560	upregulated	entinostat results in increased expression of GABRB1 mRNA	4p12	A21035
Entinostat	Investigational	GABRB2	2561	upregulated	entinostat results in increased expression of GABRB2 mRNA	5q34	A21035
Entinostat	Investigational	GABRB3	2562	downregulated	entinostat results in decreased expression of GABRB3 mRNA	15q12	A21035
Entinostat	Investigational	GABRB3	2562	upregulated	entinostat results in increased expression of GABRB3 mRNA	15q12	A21037
Entinostat	Investigational	GABRD	2563	upregulated	entinostat results in increased expression of GABRD mRNA	1p36.33	A21035
Entinostat	Investigational	GABRG3	2567	upregulated	entinostat results in increased expression of GABRG3 mRNA	15q12	A21035
Entinostat	Investigational	GAD1	2571	upregulated	entinostat results in increased expression of GAD1 mRNA	2q31.1	A21037
Entinostat	Investigational	GAD2	2572	downregulated	entinostat results in decreased expression of GAD2 mRNA	10p12.1	A21035
Entinostat	Investigational	GADD45B	4616	upregulated	entinostat results in increased expression of GADD45B mRNA	19p13.3	A21037 A21035
Entinostat	Investigational	GAL	51083	upregulated	entinostat results in increased expression of GAL mRNA	11q13.2	A21037
Entinostat	Investigational	GALC	2581	downregulated	entinostat results in decreased expression of GALC mRNA	14q31.3	A21037
Entinostat	Investigational	GALK1	2584	upregulated	entinostat results in increased expression of GALK1 mRNA	17q25.1	A21035
Entinostat	Investigational	GALNT10	55568	upregulated	entinostat results in increased expression of GALNT10 mRNA	5q33.2	A21035
Entinostat	Investigational	GALNT12	79695	upregulated	entinostat results in increased expression of GALNT12 mRNA	9q22.33	A21035
Entinostat	Investigational	GALNT14	79623	upregulated	entinostat results in increased expression of GALNT14 mRNA	2p23.1	A21035
Entinostat	Investigational	GALNT3	2591	upregulated	entinostat results in increased expression of GALNT3 mRNA	2q24.3	A21037
Entinostat	Investigational	GALNT6	11226	upregulated	entinostat results in increased expression of GALNT6 mRNA	12q13.13	A21037 A21035
Entinostat	Investigational	GALP	85569	downregulated	entinostat results in decreased expression of GALP mRNA	19q13.43	A21037
Entinostat	Investigational	GALP	85569	upregulated	entinostat results in increased expression of GALP mRNA	19q13.43	A21035
Entinostat	Investigational	GAMT	2593	upregulated	entinostat results in increased expression of GAMT mRNA	19p13.3	A21035
Entinostat	Investigational	GAP43	2596	upregulated	entinostat results in increased expression of GAP43 mRNA	3q13.31	A21037
Entinostat	Investigational	GAS1	2619	downregulated	entinostat results in decreased expression of GAS1 mRNA	9q21.33	A21037

Displaying entries 37251 - 37275 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability